Gross profit increased 24.6%
Gross profit changed +24.6% from the comparable as-filed period.
$121.9M→$151.9M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →BRZE financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
SBC / revenue moved 626 bp lower
SBC / revenue changed -626 basis points from the comparable as-filed period.
21.96%→15.69%2 prior comparisons
Operating cash-flow margin moved 680 bp higher
Operating cash-flow margin changed +680 basis points from the comparable as-filed period.
3.86%→10.66%2 prior comparisons
Capital expenditure decreased 55.2%
Capital expenditure changed -55.2% from the comparable as-filed period.
$2.6M→$1.2M3 prior comparisons
Free-cash-flow margin moved 773 bp higher
Free-cash-flow margin changed +773 basis points from the comparable as-filed period.
2.41%→10.14%2 prior comparisons
Gross margin moved 85 bp lower
Gross margin changed -85 basis points from the comparable as-filed period.
67.67%→66.83%2 prior comparisons
R&D / revenue moved 298 bp lower
R&D / revenue changed -298 basis points from the comparable as-filed period.
22.90%→19.92%2 prior comparisons
Working capital / assets moved 223 bp lower
Working capital / assets changed -223 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
12.80%→10.57%4 prior comparisons
Total assets increased 10.6%
Total assets changed +10.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$1.0B→$1.1B4 prior comparisons
Research & development increased 9.8%
Research & development changed +9.8% from the comparable as-filed period.
$41.3M→$45.3M2 prior comparisons
Capex / revenue moved 93 bp lower
Capex / revenue changed -93 basis points from the comparable as-filed period.
1.45%→0.51%2 prior comparisons
Stock-based compensation decreased 9.8%
Stock-based compensation changed -9.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$39.5M→$35.7M2 prior comparisons
Working capital decreased 8.6%
Working capital changed -8.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$130.8M→$119.6M4 prior comparisons
Current ratio decreased 7.6%
Current ratio changed -7.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
1.37→1.274 prior comparisons
Receivables / revenue moved 51 bp higher
Receivables / revenue changed +51 basis points from the comparable as-filed period.
48.98%→49.50%2 prior comparisons
Gross profit increased 24.7%
Gross profit changed +24.7% from the comparable as-filed period.
$111.2M→$138.7M2 prior comparisons
Research & development increased 25.3%
Research & development changed +25.3% from the comparable as-filed period.
$36.8M→$46.1M2 prior comparisons
Net income increased 25.7%
Net income changed +25.7% from the comparable as-filed period.
-$35.8M→-$26.6M2 prior comparisons
Total assets increased 22.7%
Total assets changed +22.7% from the comparable as-filed period.
$889.1M→$1.1B3 prior comparisons
Stockholders' equity increased 22.6%
Stockholders' equity changed +22.6% from the comparable as-filed period.
$474.4M→$581.7M2 prior comparisons
Current ratio decreased 35.4%
Current ratio changed -35.4% from the comparable as-filed period.
1.92→1.243 prior comparisons
Working capital / assets moved 2582 bp lower
Working capital / assets changed -2582 basis points from the comparable as-filed period.
35.46%→9.64%3 prior comparisons
Capital expenditure decreased 50.2%
Capital expenditure changed -50.2% from the comparable as-filed period.
$217,000→$108,0002 prior comparisons
Receivables / revenue moved 302 bp higher
Receivables / revenue changed +302 basis points from the comparable as-filed period.
53.12%→56.15%2 prior comparisons
Current assets decreased 17.1%
Current assets changed -17.1% from the comparable as-filed period.
$659.1M→$546.7M3 prior comparisons
SBC / revenue moved 194 bp lower
SBC / revenue changed -194 basis points from the comparable as-filed period.
18.91%→16.97%2 prior comparisons
Stock-based compensation increased 16.8%
Stock-based compensation changed +16.8% from the comparable as-filed period.
$30.6M→$35.8M2 prior comparisons
Operating cash-flow margin moved 157 bp lower
Operating cash-flow margin changed -157 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
14.90%→13.33%2 prior comparisons
Free-cash-flow margin moved 149 bp lower
Free-cash-flow margin changed -149 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
14.76%→13.28%2 prior comparisons
Capex / revenue moved 8 bp lower
Capex / revenue changed -8 basis points from the comparable as-filed period.
0.13%→0.05%2 prior comparisons
R&D / revenue moved 86 bp lower
R&D / revenue changed -86 basis points from the comparable as-filed period.
22.71%→21.85%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.